Why a Name Change Is a Brilliant Move for These 2 Canadian Companies

For Canadian companies Bausch Health Companies Inc. (TSX:BHC)(NYSE:BHC) and Bombardier, Inc. (TSX:BBD.B), a name change has made all the difference for investors.

| More on:
letters saying Time For Change

For publicly traded companies, investors often have long-term memory with respect to scandals, particularly those that have resulted in significant share price declines in recent years.

In this article, I’m going to discuss two companies in the midst of turnaround efforts and why these firms have picked a great time to put a new name on their doors.

Bausch Health Companies

For investors in Valeant Pharmaceuticals, the past three years have certainly been a bumpy ride. An over-leveraged balance sheet due to acquisitions made in the pharmaceutical space that relied on ever-increasing prices and relatively relaxed regulatory oversight have put the company’s balance sheet at risk.

The recently re-named company Bausch Health Companies (TSX:BHC)(NYSE:BHC) has a new name and a relatively new management team, which has put a number of strategies in place to pay down debt, refinance existing debt, and increase cash flow, providing a much-needed share price boost to investors who held on or who doubled down in 2017/2018.

As it turns out, Valeant/Bausch has certainly become one of the best contrarian plays for investors looking for beaten-up stocks in recent years — if the company’s management team can continue to do what it says it is going to do, this may be only the beginning of a long-term revival for shareholders.

Bombardier

One company I have been markedly more bearish on in recent years is Bombardier (TSX:BBD.B) for a number of reasons and scandals which have “flown under the radar,” so to speak, for many investors of late.

Say what you want about the company’s majority sale of its CSeries plane to Airbus SA (and I’ve commented quite a bit on this), but having the backing of a major international player in the aerospace industry is something shareholders apparently direly needed. The decision of Airbus to re-name the CSeries program to the A220 has been linked to new orders for this niche jet, and expectations are that this program may in fact turn profitable in the years to come, despite significant manufacturing changes that will need to be made to eliminate the threat of tariffs over the long run from the U.S.

I’m not yet ready to turn bullish on Bombardier stock, but for investors who are buying into the long-term story here, I would recommend revisiting many of the alleged issues with how the company’s management team has obtained contracts around the world before jumping in with two feet. Any additional regulatory scrutiny would certainly be a headwind for shareholders, and while Bombardier very clearly has the current Canadian federal government backing the outfit, political change could result in a light being shone on Bombardier and revealing more of what may be beneath the surface.

Stay Foolish, my friends.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool owns shares of Bausch Health Companies. Fool contributor Chris MacDonald has no position in any companies mentioned in this article.

More on Tech Stocks

A data center engineer works on a laptop at a server farm.
Tech Stocks

3 No-Brainer Data Centre Stocks to Buy With $500 Right Now

Data centres are going to be a huge growth opportunity in the next decade. And these are the top buys.

Read more »

The virtual button with the letters AI in a circle hovering above a keyboard, about to be clicked by a cursor.
Tech Stocks

Is OpenText Stock a Buy, Sell, or Hold for 2025?

OpenText stock has fallen in the last few years, but that could mean this top tech stock remains an undervalued…

Read more »

AI microchip
Tech Stocks

Celestica Stock: Buy, Sell, or Hold?

Celestica's stock price has rallied 950% in the last five years. Will the AI boom send it even higher in…

Read more »

data analyze research
Tech Stocks

2 Ridiculously Cheap Growth Stocks to Buy Hand Over Fist in 2024

Well Health Technologies is a cheap growth stock to buy for its record-breaking results, massive revenue growth, and profitability.

Read more »

A worker uses a double monitor computer screen in an office.
Tech Stocks

4 Reasons to Buy Kinaxis Stock Like There’s No Tomorrow

Kinaxis stock has a strong past. But there is even more to look forward to from this top tech stock.

Read more »

The letters AI glowing on a circuit board processor.
Tech Stocks

The Future of AI: Best Canadian Stocks to Buy Now

Here are two of the best AI-focused stocks in Canada that you can consider adding to your portfolio before it’s…

Read more »

TFSA (Tax-Free Savings Account) on wooden blocks and Canadian one hundred dollar bills.
Tech Stocks

2 TFSA Stocks to Buy Right Now With $7,000

Are you looking for growth stocks that can help you maximize the tax-free withdrawals of the TFSA? This article is…

Read more »

cloud computing
Tech Stocks

3 No-Brainer Tech Stocks to Buy Right Now for Less Than $1,000

Not all tech stocks are the risky investments that many think they are. Which is why we're focusing on the…

Read more »